Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
What tidal volume or minute ventilation goals do you target when titrating NIPPV in a patient with a hypercapneic COPD exacerbation?
Do the findings of the
HAPPEN
trial influence your approach?
Related Questions
In patients presenting with disabling acute ischemic stroke symptoms early in the therapeutic window, would you consider anticoagulation reversal to enable administration of intravenous thrombolytics?
Do you find there is any benefit to giving N-acetyl-cysteine in non-acetaminophen related acute liver failure?
How do you manage PEEP in a morbidly patient with severe hypoxia who is already proned with no access to esophageal ballon?
How do you weigh the benefit of urinary catheter placement for strict I/O measurement with the risk of avoidable CAUTI?
Do you commonly observe acute erythrocytosis in patients with ILD flares being treated with supplemental oxygen and high-dose corticosteroids?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
How would you manage a patient with necrotizing pneumonia due to a susceptible Pseudomonas aeruginosa strain who continues to have significant purulent secretions and worsening imaging while receiving cefepime?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?